Role of BCR-ABL1 isoforms on the prognosis of Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A meta-analysis.

Zhang, Wanhua; Kuang, Pu; Liu, Ting

Zhang, Wanhua; Kuang, Pu; Liu, Ting.

Affiliation

Zhang W; Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Kuang P; Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Liu T; Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.

PLoS One ; 15(12): e0243657, 2020.

Article in En | MEDLINE | ID: mdl-33338050

Subject(s)

Fusion Proteins, bcr-abl/genetics; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy; Protein Kinase Inhibitors/therapeutic use; Disease-Free Survival; Humans; Mutation; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics; Precursor Cell Lymphoblastic Leukemia-Lymphoma/mortality; Prognosis; Protein Isoforms/genetics

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Philadelphia Chromosome / Fusion Proteins, bcr-abl / Protein Kinase Inhibitors / Precursor Cell Lymphoblastic Leukemia-Lymphoma Type of study: Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: PLoS One Year: 2020 Document type: Article

Fulltext

XML

PubMed Links

Search on Google